Increasing value in the Veterans Affairs Healthcare System (VA) with precision health: a continuing landmark collaboration with the Department of Energy.
OpenAlex 토픽 ·
Health Systems, Economic Evaluations, Quality of Life
Healthcare cost, quality, practices
Healthcare Policy and Management
[OBJECTIVE] Phase II of MVP-CHAMPION, a federal collaboration between the Veterans Affairs Healthcare System (VA) and the Department of Energy (DoE), leveraged large-scale clinical, geo-spatial, and g
APA
Amy C. Justice, Benjamin H. McMahon, et al. (2026). Increasing value in the Veterans Affairs Healthcare System (VA) with precision health: a continuing landmark collaboration with the Department of Energy.. Journal of the American Medical Informatics Association : JAMIA. https://doi.org/10.1093/jamia/ocag062
MLA
Amy C. Justice, et al.. "Increasing value in the Veterans Affairs Healthcare System (VA) with precision health: a continuing landmark collaboration with the Department of Energy.." Journal of the American Medical Informatics Association : JAMIA, 2026.
PMID
42035288
Abstract
[OBJECTIVE] Phase II of MVP-CHAMPION, a federal collaboration between the Veterans Affairs Healthcare System (VA) and the Department of Energy (DoE), leveraged large-scale clinical, geo-spatial, and genetic data with state-of-the-art artificial intelligence (AI), and high-performance computing (HPC) to improve value in healthcare.
[MATERIALS AND METHODS] Eight clinical priority projects for which AI was a critical missing capability were initiated to address: lung cancer screening (MVP 061), suicide risk screening (MVP 062), cardiovascular risk in obstructive sleep apnea (MVP 063), checkpoint inhibitor toxicity (MVP 064), heart failure (MVP 065), renal complications in diabetes (MVP 066), post COVID-19 sequelae (MVP 067), and antipsychotic medication toxicity (MVP 068).
[RESULTS] Building on a strong regulatory and administrative foundation, we developed multimorbidity-aware analytic frameworks, reusable computational tools, and analytic pipelines. These greatly facilitated identification of novel risk factors including genetic variants and specification of more discriminating prediction models. Novel genetic risk factors are informing development and repurposing of medications and discriminating prediction models promise to improve healthcare value.
[DISCUSSION] The research foundation developed in Phase I and extended in Phase II of MVP CHAMPION has supported an unprecedented federal collaboration and yielded significant scientific advances. Our clinical findings are poised for near-term application, while advances in machine learning and high-performance computing may accelerate the broader adoption of artificial intelligence in healthcare.
[CONCLUSION] This maturing VA-DoE federal collaboration is poised to transform the future of Veterans' healthcare and the broader national landscape of precision health.
[MATERIALS AND METHODS] Eight clinical priority projects for which AI was a critical missing capability were initiated to address: lung cancer screening (MVP 061), suicide risk screening (MVP 062), cardiovascular risk in obstructive sleep apnea (MVP 063), checkpoint inhibitor toxicity (MVP 064), heart failure (MVP 065), renal complications in diabetes (MVP 066), post COVID-19 sequelae (MVP 067), and antipsychotic medication toxicity (MVP 068).
[RESULTS] Building on a strong regulatory and administrative foundation, we developed multimorbidity-aware analytic frameworks, reusable computational tools, and analytic pipelines. These greatly facilitated identification of novel risk factors including genetic variants and specification of more discriminating prediction models. Novel genetic risk factors are informing development and repurposing of medications and discriminating prediction models promise to improve healthcare value.
[DISCUSSION] The research foundation developed in Phase I and extended in Phase II of MVP CHAMPION has supported an unprecedented federal collaboration and yielded significant scientific advances. Our clinical findings are poised for near-term application, while advances in machine learning and high-performance computing may accelerate the broader adoption of artificial intelligence in healthcare.
[CONCLUSION] This maturing VA-DoE federal collaboration is poised to transform the future of Veterans' healthcare and the broader national landscape of precision health.